Aktienanalyse zu Encompass Health Corp (EHC)EHCEncompass Health Corp

Encompass Health Corporation is a provider of inpatient rehabilitation services. The Company provides specialized rehabilitative treatment, using technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability. It operates hospitals in approximately 39 states and Puerto Rico, with concentrations in Florida and Texas. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver patient care services. It offers neurological, spinal & brain-related rehabilitation, which include brain injury rehabilitation, multiple trauma rehabilitation, neurological rehabilitation, spasticity management, spinal cord injury rehabilitation and stroke rehabilitation. It also offers orthopedic & joint-related rehabilitation, which includes amputee rehabilitation, chronic condition management, hip rehabilitation and orthopedic rehabilitation. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Encompass Health Corp is a good buy right now due to its current price of $120.85, which is significantly below the average analyst price target of $144, indicating a potential upside of 19%. Additionally, the company has shown a strong financial performance with a gross margin of 90.20% and a year-to-date change of +13.61%, reflecting robust operational efficiency and growth. However, there is a risk from insider selling, as the CFO sold 18,869 shares, which may indicate some caution among executives.